Concepedia

Jenny Xie

JX

Statistics

Publications

29

Citations

3K

H-Index

20

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Biocon (India)

Bristol-Myers Squibb (India)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Jenny Xie is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, drug discovery, and immunology.

ORCID

Publications per year

2002–2021

29

Publications

29

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

, , +17

Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain

James R. Burke, Lihong Cheng, Kathleen M. Gillooly et al. · Science Translational Medicine · 2019 · 282 citations

, , +14

Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation

Jenny Xie, Naomi Nomura, Min Lu et al. · Journal of Leukocyte Biology · 2003 · 170 citations

, , +16

Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4+ T Cells

Jenny Xie, Naomi Nomura, Sam L. Koprak et al. · The Journal of Immunology · 2003 · 118 citations

, , +17

Engineering of a Novel Anti-CD40L Domain Antibody for Treatment of Autoimmune Diseases

Jenny Xie, Aaron P. Yamniuk, Virna Borowski et al. · The Journal of Immunology · 2014 · 70 citations

, , +12

1–5 of 29